- Home
- GSL vs OCS Comparison
GSL vs OCS Comparison
Compare GSL & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSL
- OCS
- Stock Information
- Founded
- GSL 2007
- OCS 2003
- Country
- GSL Greece
- OCS Switzerland
- Employees
- GSL N/A
- OCS N/A
- Industry
- GSL Marine Transportation
- OCS Biotechnology: Pharmaceutical Preparations
- Sector
- GSL Consumer Discretionary
- OCS Health Care
- Exchange
- GSL Nasdaq
- OCS Nasdaq
- Market Cap
- GSL 1.1B
- OCS 956.4M
- IPO Year
- GSL 2006
- OCS N/A
- Fundamental
- Price
- GSL $31.92
- OCS $17.40
- Analyst Decision
- GSL Strong Buy
- OCS Strong Buy
- Analyst Count
- GSL 1
- OCS 4
- Target Price
- GSL $33.00
- OCS $35.75
- AVG Volume (30 Days)
- GSL 317.1K
- OCS 13.9K
- Earning Date
- GSL 11-10-2025
- OCS 11-06-2025
- Dividend Yield
- GSL 6.58%
- OCS N/A
- EPS Growth
- GSL 19.05
- OCS N/A
- EPS
- GSL 10.76
- OCS N/A
- Revenue
- GSL $730,277,000.00
- OCS $960,668.00
- Revenue This Year
- GSL $5.44
- OCS $11.49
- Revenue Next Year
- GSL N/A
- OCS $1,784.02
- P/E Ratio
- GSL $2.97
- OCS N/A
- Revenue Growth
- GSL 4.04
- OCS N/A
- 52 Week Low
- GSL $17.73
- OCS $11.78
- 52 Week High
- GSL $32.45
- OCS $23.08
- Technical
- Relative Strength Index (RSI)
- GSL 69.71
- OCS 50.18
- Support Level
- GSL $31.00
- OCS $16.00
- Resistance Level
- GSL $31.78
- OCS $17.34
- Average True Range (ATR)
- GSL 0.51
- OCS 0.41
- MACD
- GSL 0.09
- OCS 0.08
- Stochastic Oscillator
- GSL 83.28
- OCS 66.67
About GSL Global Ship Lease Inc New
Global Ship Lease Inc operates in the container shipping industry. The company owns and charters out containerships under long-term, fixed-rate charters to container liner companies. The majority of the company's revenues are derived from charters to MAERSK. Its fleet consisted of more than 60 containerships.
About OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.